Published in Am J Physiol on January 01, 1981
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev (2016) 1.25
Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol (2011) 1.19
Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys (2012) 0.98
Abnormal vitamin D metabolism, intestinal calcium transport, and bone calcium status in the spontaneously hypertensive rat compared with its genetic control. J Clin Invest (1986) 0.92
Unanticipated stimulatory action of glucocorticoids on epithelial calcium absorption. Effect of dexamethasone on rat distal colon. J Clin Invest (1983) 0.76
Expression of Cav1.3 calcium channel in the human and mouse colon: post-transcriptional inhibition by IFNγ. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern Med (1978) 2.72
Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med (1989) 2.40
Acute interstitial nephritis due to methicillin. Am J Med (1978) 2.11
Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol (2000) 2.05
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. Am J Physiol (1967) 1.72
Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med (1985) 1.68
Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg (1994) 1.67
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.66
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med (1969) 1.64
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost (2007) 1.51
The role of ecgonine methyl ester in the interpretation of cocaine concentrations in postmortem blood. J Anal Toxicol (1993) 1.51
Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg (1994) 1.49
The adult Fanconi syndrome: observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine (Baltimore) (1972) 1.46
Hydrocarbons and renal failure. Nephron (1991) 1.46
Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J (2001) 1.46
Study of intestinal absorption of calcium in patients with renal failure. Kidney Int (1973) 1.45
Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. Kidney Int Suppl (1974) 1.43
Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis (1991) 1.43
Stress produced by gavage administration in the rat. Contemp Top Lab Anim Sci (2000) 1.41
An infected right atrial thrombus--a new complication of haemodialysis associated subclavian vein catheterisation. Nephrol Dial Transplant (1994) 1.41
changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J Clin Invest (1972) 1.39
Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med (1972) 1.39
Renal failure in older people. J Am Geriatr Soc (1990) 1.39
Genetic counseling in adult polycystic kidney disease in Israel. Nephron (1990) 1.38
Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med (1982) 1.37
Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy. Am J Med (1970) 1.33
A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol (2001) 1.31
Granulomatous sarcoid nephritis. Am J Med (1967) 1.31
The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med (1982) 1.30
A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int (2000) 1.29
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care (2000) 1.28
Candida peritonitis. Report of 22 cases and review of the English literature. Am J Med (1976) 1.27
The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. J Clin Invest (1969) 1.26
Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab (1982) 1.26
IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol (1993) 1.26
The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med (1969) 1.26
1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. Ann Intern Med (1974) 1.25
Advances in vitamin D metabolism as they pertain to chronic renal disease. Am J Clin Nutr (1976) 1.25
Bone disease in burn patients. J Bone Miner Res (1993) 1.23
Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med (1976) 1.23
Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood (1990) 1.22
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol (2008) 1.22
Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium. Medicine (Baltimore) (1973) 1.21
Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.21
Abnormalities of the musculoskeletal system in hemodialysis patients. Semin Arthritis Rheum (1975) 1.21
Microradiographic studies of bone in renal osteodystrophy. Arch Intern Med (1969) 1.19
Effects of 1 alpha,25-, 24R,25-, and 1 alpha,24R,25-hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. Arch Biochem Biophys (1977) 1.19
The acute effects of static stretching on peak torque, mean power output, electromyography, and mechanomyography. Eur J Appl Physiol (2004) 1.19
Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr (1980) 1.18
Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int (2004) 1.15
The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure. Arch Intern Med (1969) 1.12
Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest (1970) 1.10
Aplastic anemia followed by leukemia in congenital trisomy 8 mosaicism. Ultrastructural studies of polymorphonuclear cells in peripheral blood. Clin Genet (1976) 1.09
Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone (1995) 1.09
Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe? J Med Ethics (2010) 1.07
Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest (1970) 1.07
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol (2000) 1.07
Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol (1994) 1.07
Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism. J Clin Invest (1973) 1.06
Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr (1991) 1.06
Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation. Arch Intern Med (1969) 1.04
Aluminum and renal osteodystrophy. Annu Rev Med (1986) 1.03
Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest (1976) 1.03
Magnesium, the mimic/antagonist to calcium. N Engl J Med (1984) 1.03
Protein losses during peritoneal dialysis. Kidney Int (1981) 1.03
Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med (1972) 1.02
Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med (1970) 1.02
Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. Kidney Int (1974) 1.02
Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int (1981) 1.02
Haematological complications of chlorate poisoning. Br Med J (1970) 1.01
Isolation and characterization of Neurospora mutants affected in invertase synthesis. Genetics (1984) 1.01
Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med (1984) 1.00
Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. Ann Intern Med (1973) 1.00
Aluminum loading during total parenteral nutrition. Am J Clin Nutr (1982) 0.99
Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int (1988) 0.99
Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution. J Clin Endocrinol Metab (1973) 0.99
Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. Kidney Int (1976) 0.99
Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. J Clin Invest (1972) 0.99
Intestinal absorption of calcium and the effect of renal insufficiency. Kidney Int (1973) 0.99
An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm Res (2003) 0.99
Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res (1995) 0.99
A questionnaire to evaluate disability in osteoporotic patients with vertebral compression fractures. J Gerontol A Biol Sci Med Sci (1995) 0.98
Renal handling of magnesium in the dog. Am J Physiol (1969) 0.98
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer (1996) 0.98
Excretion of phosphate and calcium. Physiology of their renal handling and relation to clinical medicine. Arch Intern Med (1973) 0.98
Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances. Am J Physiol (1968) 0.98
Calcific periarthritis and hemodialysis. JAMA (1973) 0.98
Acute renal failure, Viet Nam, 1965: transglobal treatment. Mil Med (1965) 0.97
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med (2001) 0.97
Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int (1982) 0.96
Intestinal phosphate absorption: influence of vitamin D and non-vitamin D factors. Am J Physiol (1986) 0.96
Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels. J Immunol (1997) 0.96
The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog. Endocrinology (1979) 0.95
Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. N Engl J Med (1973) 0.95